Corcept Therapeutics Incorporated (CORT)

Interest coverage

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 136,196 142,603 127,512 120,937 105,550 96,380 97,306 99,978 112,634 126,799 131,097 131,608 124,477 118,323 106,810 110,129 128,202 132,708 140,993 130,364
Interest expense (ttm) US$ in thousands 0 3,581 3,581 3,581 7,162 5,358 6,428 7,058 3,557 1,852 854 334 529 754 1,304 2,204 3,400 4,547 5,273 5,441
Interest coverage — 39.82 35.61 33.77 14.74 17.99 15.14 14.17 31.67 68.47 153.51 394.04 235.31 156.93 81.91 49.97 37.71 29.19 26.74 23.96

December 31, 2024 calculation

Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $136,196K ÷ $0K
= —

Corcept Therapeutics Incorporated's interest coverage ratio has demonstrated a generally improving trend from March 31, 2020, to March 31, 2024. The interest coverage ratio measures the company's ability to cover its interest expenses with its operating income.

During this period, the interest coverage ratio increased significantly from 23.96 on March 31, 2020, reaching its peak of 394.04 on March 31, 2022. This substantial improvement indicates that Corcept Therapeutics Incorporated has been able to generate ample operating income to comfortably cover its interest obligations, reflecting strong financial health and stability.

However, there was a notable decline in the interest coverage ratio in subsequent periods, dropping to 14.74 on December 31, 2023, before recovering slightly to 33.77 on March 31, 2024. This reduction may raise concerns about the company's ability to service its debt effectively with its operating income.

Overall, the fluctuating trend in the interest coverage ratio of Corcept Therapeutics Incorporated highlights the importance of closely monitoring the company's financial performance and debt management practices to ensure continued stability and growth.